Lenzetto estradiol spray

Lenzetto is a transdermal estradiol spray used for hormone replacement therapy (HRT) in postmenopausal women. Developed by Acrux Limited, an Australian pharmaceutical company, Lenzetto was licensed to Gedeon Richter Plc., a Hungarian multinational pharmaceutical company, for commercialization in the European Union. The product is manufactured in multiple countries, including Romania. Lenzetto is applied to the skin, where it delivers estradiol, a form of estrogen, directly into the bloodstream, providing systemic estrogen replacement therapy. This method helps alleviate menopausal symptoms by compensating for the loss of estrogen production in postmenopausal women. The spray is clear and dries quickly upon application, minimizing skin irritation. Lenzetto is available in various markets, including the European Union and South America, and is prescribed to manage symptoms such as hot flashes and mood changes associated with menopause.